NBIX vs OKUR · P/E 45, rev $1.77B vs P/E 72, rev $2.0M
Neurocrine Biosciences Inc (NBIX) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the NBIX and OKUR stock pages for the full models.
Not investment advice.